Implantable progestin in the form of Norplant was approved by the U.S. Food and Drug Administration (FDA) for contraception in 1990 and the newer Norplant 2 was approved in 1996 for contraception.
Made up of matchstick-sized rubber rods, this contraceptive device is surgically implanted under the skin of the woman's upper arm, where it steadily releases a contraceptive substance (a progestin hormone called levonorgestrel).
The six-rod Norplant provides protection for up to five years (or until it is removed), while the two-rod Norplant 2 protects for up to three years.
Norplant failures are rare but are higher with increased body weight (in heavier women).
Some women may experience inflammation or infection at the site of the implant. Other side effects include menstrual cycle changes, weight gain, and breast tenderness.
medical
dictionary, online medical dictionary, medical
terminology dictionary, free online medical
dictionary, medical dictionary, online medical
dictionary, medical terminology dictionary, free
online medical dictionary, dictionary medical,
dictionary medical online, dictionary medical
terminology, dictionary free medical online,
dictionary free medical, dictionary medical
terms, dictionary drug medical medicine,
dictionary health illustrated medical nursing
profession stedmans, dictionary English medical,
dictionary medical online terminology,
dictionary encyclopedia medical online,
condition dictionary medical, dictionary
medical, dictionary drug medical, medical
dictionary software, cyclopedic dictionary index
medical tabers thumb, medical dictionary, online
medical dictionary, medical terminology
dictionary
